![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Shi Li Schofield Timothy
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.3, Iss.2, 2004-03, pp. : 153-158
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The 134th British Pharmaceutical Conference
By Denny W.A.
Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
News from the 137th British Pharmaceutical Conference
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 288, 2000-01 ,pp. :